Information about Rocky Mountain MS Research Group Clinical Trials

CURRENT MULTIPLE SCLEROSIS CLINICAL STUDIES SPONSORED BY PHARMACEUTICAL COMPANIES

At Rocky Mountain MS Research Group, we have several studies current enrolling for patients with Relapsing Remitting Multiple Sclerosis (RRMS).

One of the federal guidelines that we must follow is that any information about a study that will be presented to potential participants in a study has to be approved by an Independent Review Board (IRB) prior to sharing. Due to this federal guideline, we cannot share specific information about a study unless it has been IRB approved.

We have a study for patients that are JCV antibody negative and are just beginning treatment with natalizumab.

If you are interested in getting further information about any of these studies, you can call the Rocky Mountain MS Research Group Research Office at 801-408-5700. Information for all studies conducted in the United States must be posted on ClinicalTrials.gov.